- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05788458
Effect of Bupivacaine Concentration on Ultrasound Guided Pericapsular Group Nerve Block Efficacy in Hip Surgery Patients
Effect of Bupivacaine Concentration on Ultrasound Guided Pericapsular Group Nerve Block Efficacy in Hip Surgery Patients: A Randomized Controlled Double Blinded Trial
Study Overview
Detailed Description
Fractures in and around the hip are quite common irrespective of both the young and elderly population groups and are associated with extreme pain. A hip fracture is a serious injury, with complications that can be life-threatening and is a common orthopedic emergency in the elderly. Early surgery within 48 h of fracture has shown to decrease the complication and mortality rates.
Spinal anaesthesia is the most common mode of anaesthesia used to fix these fractures. Extreme pain due to fracture does not allow ideal positioning for these procedures. and hence a problem to access the subarachnoid space. Inadequate postoperative analgesia can restrict the limb mobility thereby delaying recovery along with increased consumption of opioids.
Effective perioperative analgesia that reduces the requirement of opioids and its adverse effects is essential in this population.
The anterior hip capsule is innervated by articular branches of femoral nerve, obturator nerve and accessory obturator nerve (AON) as reported by previous anatomic studies, suggesting that these nerves should be the main targets for hip analgesia, which can be blocked by Peri-capsular nerve group (PENG) .
PNB with lower volume and higher concentration of local anesthetic was more efficacious than higher volumes and lower concentrations of local anesthetic of equivalent dose.
Using this information, the investigators will conduct this study to evaluate the efficacy of bupivacaine at three different concentration and doses in equivalent volume used in ultrasound guided PENG block for positioning & post-operative analgesia.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Elqalyoubea
-
Banha, Elqalyoubea, Egypt, 13511
- Banha Faculity of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- (ASA )classes I and II
- patients of either sex
- above the age of 18 who will undergo hip surgeries( (Dynamic hip screw fixation or hemiarthroplasty)(not older than 2 weeks) with persistent pain and scheduled for surgery under SA with an expected duration of 2.5 hours).
Exclusion Criteria:
- patient's refusal to participate
- any contraindications to SA or peripheral nerve blocks
- history of ischemic heart disease
- patients on opioids for chronic pain
- patients with significant cognitive impairment.
- Patients who have surgery on the hip or spine within 3 months or have no pain while sitting by themselves (resting pain less than 4 on NRS) for SA without any support
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A
will receive 20 ml of 0.25 % bupivacaine
|
The blocks will be performed in supine position under complete aseptic condition.
The site to be blocked will be painted with 5% povidone iodine followed by 70% ethyl alcohol and draped.
Linear high-frequency ultrasound probe (7 -15 mhz) (General Electric; GE, "LOGIQ E") will be initially placed in a transverse plane over the anterior superior iliac spine (ASIS) and then alignes to identify the following landmarks: Anterior inferior iliac spine, ilio-pubic eminence, iliopsoas muscle and tendon, the femoral artery, and Pectineus muscle.
Point of injection will be musculo-fascial plane between the psoas tendon and ilio-pubic eminence.
|
|
Active Comparator: Group B
will receive 20 ml of 0.375 % bupivacaine.
|
The blocks will be performed in supine position under complete aseptic condition.
The site to be blocked will be painted with 5% povidone iodine followed by 70% ethyl alcohol and draped.
Linear high-frequency ultrasound probe (7 -15 mhz) (General Electric; GE, "LOGIQ E") will be initially placed in a transverse plane over the anterior superior iliac spine (ASIS) and then alignes to identify the following landmarks: Anterior inferior iliac spine, ilio-pubic eminence, iliopsoas muscle and tendon, the femoral artery, and Pectineus muscle.
Point of injection will be musculo-fascial plane between the psoas tendon and ilio-pubic eminence.
|
|
Active Comparator: Group C
will receive 20 ml of 0.5 % bupivacaine.
|
The blocks will be performed in supine position under complete aseptic condition.
The site to be blocked will be painted with 5% povidone iodine followed by 70% ethyl alcohol and draped.
Linear high-frequency ultrasound probe (7 -15 mhz) (General Electric; GE, "LOGIQ E") will be initially placed in a transverse plane over the anterior superior iliac spine (ASIS) and then alignes to identify the following landmarks: Anterior inferior iliac spine, ilio-pubic eminence, iliopsoas muscle and tendon, the femoral artery, and Pectineus muscle.
Point of injection will be musculo-fascial plane between the psoas tendon and ilio-pubic eminence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NRS at rest and on passive 15° limb lifting, EOSP.
Time Frame: 30 minutes after the block
|
From 0 to 10 (0 no pain , 10 very sever pain)
|
30 minutes after the block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NRS over 24 hours
Time Frame: 2,4,8,16,24 hours postoperative
|
From 0 to 10 (0 no pain , 10 very sever pain)
|
2,4,8,16,24 hours postoperative
|
|
Amount of morphine intake.
Time Frame: 24 hours postoperative
|
Amount of morphine taken during 24 hours
|
24 hours postoperative
|
|
Quality of recovery score (QoR-15)
Time Frame: at 24 hours postoperative
|
This questionnaire covers a total of 15 questions under five clinical dimensions of health; physical comfort (five-item), emotional status (four-item), psychological support (two-item), physical independence (two-item) and pain (twoitem). a numerical rating scale of 11 point for each question leads to a minimum score of 0 (very poor recovery) and a maximum score of 150 (excellent recovery). |
at 24 hours postoperative
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fatma Ah Abdelfatah, MD, Banha Faculity of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC 1-3-2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perioperative Pain
-
Aretaieion University HospitalEnrolling by invitationPerioperative Pain in Robotic ProstatectomyGreece
-
Karlstad Central HospitalEnrolling by invitationGastreoesophageal Reflux Disease | Perioperative Pain ManagementSweden
-
Cairo UniversityCompleted
-
Naestved HospitalBispebjerg HospitalCompletedPerioperative PainDenmark
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Terminated
-
Assiut UniversityCompleted
-
Xsira PharmaceuticalsCompleted
-
National Cancer Institute, EgyptCompleted
-
University of California, San FranciscoRecruitingPerioperative Pain | Perioperative AnxietyUnited States
Clinical Trials on Bupivacain
-
Theodor Bilharz Research InstituteCompletedFast Track SurgeryEgypt
-
University of ChicagoRecruitingTibial Plateau FracturesUnited States
-
Ain Shams UniversityCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedPostoperative PainTurkey (Türkiye)
-
University Hospital Inselspital, BerneCompletedUrinary Retention | Analgesia, Epidural | UrodynamicsSwitzerland
-
Gaziosmanpasa Research and Education HospitalRecruitingPain Management | Anaesthesia ComplicationTurkey
-
Udayana UniversityCompletedPost Operative Pain, Acute | Gynecologic Disease | Chronic Post Surgical PainIndonesia
-
Hadassah Medical OrganizationNot yet recruitingChronic Pain Syndrome | PSP | Local Anesthesia Infiltration | Pain After Surgery
-
Sardar Umer RehmanServices Institute of Medical Sciences, PakistanRecruiting
-
Udayana UniversityCompletedGoiter | Hyperthyroidism | Thyroid CancerIndonesia